# Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

> **NCT00324675** · NA · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 28 (actual)

## Conditions studied

- Type 2 Diabetes
- Overt Diabetic Nephropathy

## Interventions

- **DRUG:** Rosiglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00324675
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-12
- **Final completion:** 2010-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324675, "Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00324675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*